<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00356629</url>
  </required_header>
  <id_info>
    <org_study_id>AOHP06-PD Air Exhalé</org_study_id>
    <nct_id>NCT00356629</nct_id>
  </id_info>
  <brief_title>Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air</brief_title>
  <official_title>Development of a Noninvasive Method of Evaluation of the Pulmonary Inflammation in the Condensates of Exhaled Air</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is identify biological parameters reflecting proteolytic activity in the
      exhaled condenstaes which might be useful to follow up pulmonary inflammation in various
      conditions including cystic fibrosis, COPD, asthma, tobacco exposure. Three proteases will be
      analyzed, i.e. elastase, proteinase 3 and cathepsin G. Results in the condensates will be
      compared to those obtained in sputum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5 groups of 20 individuals each: group 1 CF, group 2 COPD, group 3 asthma, group 4 tobacco
      exposure, group 5 control subjects.

      Collection of exhaled condensates in all subjects and of sputum in subjects belonging to
      groups 1 and 2.

      Clinical examination and PFTs in all patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Technical problem
  </why_stopped>
  <start_date>July 2006</start_date>
  <completion_date type="Anticipated">July 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bronchopulmonary Ignition</condition>
  <condition>Condensate of Exhaled Air</condition>
  <condition>Mucoviscidosis</condition>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        ubjects suffering from CF, COPD, asthma and tobacco exposure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Subjects suffering from CF, COPD, asthma and tobacco exposure (groups 1 to 4) and
             controls (group 5)

          -  aged more or equal to 18

          -  stable disease

          -  able to perform PFTs

          -  informed consent signed

          -  affiliated to french social insurance

        Exclusion Criteria:

          -  acute exacerbation of the disease during the last 2 weeks

          -  IV or oral steroids or antibiotics during the last 2 weeks

          -  hospitalization during the last 2 weeks

          -  colonization by S aureus methicillin resistant and/or Burkholderia cepacia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DIOT Patrice, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>service de Pneumologie et EFR CHRU Tours</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Pneumologie et EFR CHRU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://u618.univ-tours.fr</url>
  </link>
  <reference>
    <citation>Attucci S, Gauthier A, Korkmaz B, Delépine P, Martino MF, Saudubray F, Diot P, Gauthier F. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. J Pharmacol Exp Ther. 2006 Aug;318(2):803-9. Epub 2006 Apr 20.</citation>
    <PMID>16627747</PMID>
  </reference>
  <reference>
    <citation>Grimbert D, Vecellio L, Delépine P, Attucci S, Boissinot E, Poncin A, Gauthier F, Valat C, Saudubray F, Antonioz P, Diot P. Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosis. J Aerosol Med. 2003 Summer;16(2):121-9.</citation>
    <PMID>12823906</PMID>
  </reference>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2006</study_first_submitted>
  <study_first_submitted_qc>July 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2006</study_first_posted>
  <last_update_submitted>November 13, 2008</last_update_submitted>
  <last_update_submitted_qc>November 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>University Hospital Tours/Jocelyne Marlière</name_title>
    <organization>University Hospital Tours</organization>
  </responsible_party>
  <keyword>bronchopulmonary ignition</keyword>
  <keyword>condensate of exhaled air</keyword>
  <keyword>Mucoviscidosis</keyword>
  <keyword>Asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

